MRAM
Everspin Technologies, Inc.
MRAM's outlook is improving, though it still trails on the overall score.
MSFT
Microsoft Corporation
MSFT has the edge over MRAM overall, supported by lower modeled downside and stronger fundamentals.
MRAM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
MRAM's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
MRAM PE Valuation
MRAM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 105x next year's earnings.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
MRAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
MRAM has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
MRAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.12 | — |
| Q3 2026 | -$0.40 | -$0.39 |
MRAM lost $0.40 per share over the past year, a bigger loss than the year before.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over MRAM in the latest year-over-year earnings comparison.
MRAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.6M | +47% |
| Q2 2026 | $18.7M | +42% |
| Q1 2026 | $14.9M | +13% |
| Q4 2025 | $14.8M | +12% |
MRAM has the edge over MSFT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -23% | -8.5 points |
| Q1 2026 | -18% | -3.6 points |
| Q4 2025 | -7.2% | +4.5 points |
| Q3 2025 | -11% | N/A |
| Q2 2025 | -15% | N/A |
| Q1 2025 | -15% | N/A |
| Q4 2024 | -12% | N/A |
MRAM's operating margin was −23% last quarter, down 8.5 points from the same quarter a year ago, near the bottom of its range since 2024.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT's revenue has grown year over year every quarter since late 2020: $92.3B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over MRAM on profitability, with a higher operating margin.
MRAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2M | -138% |
| Q1 2026 | -$3.8M | -818% |
| Q4 2025 | -$975K | -147% |
MSFT has the edge over MRAM in the latest year-over-year cash flow comparison.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over MRAM in the latest year-over-year cash flow comparison.
MRAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +745K shares |
| 1 year | +6.1% | +1.4M shares |
MRAM has 24M diluted shares, up 6.1% from a year ago.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over MRAM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
MRAM Net Leverage
MRAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
MRAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 19.9 | Oversold |
MRAM's weekly RSI is 44 (neutral) and its Stochastic is 20 (oversold).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
MRAM PE vs Technology Sector
| Metric | MRAM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MRAM has no meaningful PE right now: it lost money over the past year.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
MRAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 12% below |
| 20 week MA | $15.8 | 18% below |
| 50 week MA | $15.7 | 17% below |
| 100 week MA | $11.2 | 16% above |
| 200 week MA | $9.38 | 38% above |
MRAM has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 38% above its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over MRAM on trend strength, trading above more of its moving averages.
MRAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $4.64 | -14% |
| 2021 | $4.64 | $11.1 | +139% |
| 2022 | $11.1 | $5.27 | -53% |
| 2023 | $5.27 | $9.04 | +72% |
| 2024 | $9.04 | $6.57 | -27% |
| 2025 | $6.57 | $9.38 | +43% |
| 2026 YTD | $9.38 | $12.9 | +38% |
MRAM has the edge over MSFT on returns for 2026, with the stronger performance.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.